FDA issues new policy for evaluating impact of viral mutations on COVID-19 tests
The U.S. Foods and Drug Administration (Food and drug administration) has issued new steerage for COVID-19 examination developers to appraise the impact of rising and future viral mutations on COVID-19 checks. The SARS-CoV-two virus has mutated in excess of time, generating multiple variants of the virus with various genetic sequences….
By: Hogan Lovells
